Trial Profile
Phase 4 Study of Tapentadol vs Oxycodone in Neuropathic Pain.
Status:
Discontinued
Phase of Trial:
Phase IV
Latest Information Update: 30 Oct 2020
Price :
$35
*
At a glance
- Drugs Tapentadol (Primary) ; Oxycodone
- Indications Neuropathic pain
- Focus Therapeutic Use
- 25 Mar 2014 Status changed from recruiting to discontinued as reported by ClinicalTrials.gov.
- 06 Jun 2012 Primary endpoint amended as reported by ClinicalTrials.gov.
- 16 Nov 2011 Status changed from not yet recruiting to recruiting as reported by European Clinical Trials Database.